Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31
- 30 October 2003
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 18 (1) , 113-119
Abstract
We analyzed data of 76 consecutive patients with myelodysplastic syndrome (MDS) and isolated del(5q) (n=66) or del(5q) plus one additional chromosomal abnormality (n=10) included in our MDS database over the last 26 years. The median age of our patient population was 66.8 years. The male to female ratio was 1:1.7. In all, 14 patients (18%) had advanced MDS with an increased medullary blast count. A total of 17 patients (22%) had significant dysplasia in the nonmegakaryocytic cell lines. Nearly half of the study population showed erythroid hypoplasia in the bone marrow. The projected median survival of patients with isolated del(5q) is 146 months for a median follow-up of 67 months. Patients with an increased medullary blast count and those with an additional chromosomal abnormality have a significantly shorter overall survival (24 and 45 months, respectively) than patients with isolated del(5q). We did not find survival differences for different cytogenetic breakpoints, nor did the amount of dysplasia have an impact on survival in our population. In total, 29 patients have died. Deaths occurred primarily due to transformation into acute leukemia, infection, or cardiac failure. Our data support the current definition of a separate entity of MDS with del(5q) that has been suggested by the World Health Organization.Keywords
This publication has 11 references indexed in Scilit:
- A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q− syndrome from refractory anemia in primary myelodysplastic syndromeLeukemia Research, 2003
- Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patientsLeukemia Research, 2000
- Transcription Mapping of the 5q− Syndrome Critical Region: Cloning of Two Novel Genes and Sequencing, Expression, and Mapping of a Further Six Novel cDNAsGenomics, 2000
- The 5q-syndromeBlood, 1994
- Low‐dose ARA‐C consistently induces hematologic responses in the clinical 5q–syndromeAmerican Journal of Hematology, 1994
- All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot studyBlood, 1993
- The 5q- syndrome: a single-institution study of 43 consecutive patientsBlood, 1993
- Clinical characteristics and prognosis of 50 patients with a myeloproliferative syndrome and deletion of part of the long arm of chromosome 5Blood, 1985
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Distinct haematological disorder with deletion of long arm of No. 5 chromosomeNature, 1974